Green Cross Medical Science Stock Forecast for 2023 - 2025 - 2030

Green Cross Medical Science Revenue Forecast for 2023 - 2025 - 2030

In the last three years, Green Cross Medical Science has seen a decline in its Revenue, from ₩113.38B to ₩94.01B – a 17.08% decrease. For next year, the 0 analysts predict Revenue of ₩100.82B, which would mean an increase of 7.24%. Over the next seven years, the pros' prediction is Revenueof ₩103.28B, which would mean a seven-year growth forecast of 9.86%.

Green Cross Medical Science Dividend per Share Forecast for 2023 - 2025 - 2030

Green Cross Medical Science Free Cash Flow Forecast for 2023 - 2025 - 2030

Green Cross Medical Science EBITDA Forecast for 2023 - 2025 - 2030

Green Cross Medical Science's EBITDA has decreased In the last three years, from ₩7.36B to ₩5.13B – a 30.37% drop. In the following year, 0 experts forecast Green Cross Medical Science's EBITDA will decrease by 240.20%, to ₩-7.19B. Over the next seven years, experts predict that EBITDA will grow by 33.41%.

Green Cross Medical Science EBIT Forecast for 2023 - 2025 - 2030

In the last three years, Green Cross Medical Science's EBIT has seen a drop from ₩4.20B to ₩1.27B – a 69.71% decrease. Next year, analysts are expecting EBIT to reach ₩5.06B – an increase of 297.88%. Professionals believe that By 2030, Green Cross Medical Science's EBIT will fall to ₩-21.01B– a 1752.34% decrease from its current value.

Green Cross Medical Science EPS Price Prediction Forecast for 2023 - 2025 - 2030

In the last year, Green Cross Medical Science has seen a decline in its EPS, from ₩112.23 to ₩0.00 – a 100.00% decrease. For next year, the 0 analysts predict EPS of ₩0.00, which would mean an increase of 100.00%. Over the next six years, the pros' prediction is EPSof ₩0.00, which would mean a six-year growth forecast of 100.00%.